• About
  • Privacy Policy
  • Cookie Policy
  • Terms of Use 
  • My account
  • Contact
Saturday, December 27, 2025
  • Login
Arab Health World
Advertisement
  • Home
    • About Us
    • Cookie Policy
    • Privacy Policy
    • Terms of Use 
  • Business Insights
    • Accreditation
    • Healthcare Regulation
    • Infrastructure
    • Insurance
    • Leadership
    • Medical Tourism
    • Mental health
    • Medical Investment and Finance
    • Healthcare Regulation
    • Nutrition and Healthcare Latest Trend
  • Tech
    • 3DPrinting
    • Artificial Intelligence
    • Automation
    • Blockchain
    • Big Data
    • Med Tech
    • Digital Health
    • Medical devices, equipment, and hospital supplies manufacturers
  • Clinical
    • Cardiology
    • Diabetes
    • Emergency Medicine
    • Obesitrics and Guneocology
    • Obesity
    • Oncology
    • Orthopedics
    • Otolaryngology
    • Padiatrics
    • Radiology
    • Surgery
  • Laboratories
    • Clinical Chemistry
    • Diagnostics
    • Gen Therapy
    • Immunology
    • IVF
    • Labratory Accrediation
    • Labratory Management
    • MicroBiology
  • Sectors
    • Optometry
    • Dental
    • Pharma
  • Magazine
  • Media Kit
No Result
View All Result
  • Home
    • About Us
    • Cookie Policy
    • Privacy Policy
    • Terms of Use 
  • Business Insights
    • Accreditation
    • Healthcare Regulation
    • Infrastructure
    • Insurance
    • Leadership
    • Medical Tourism
    • Mental health
    • Medical Investment and Finance
    • Healthcare Regulation
    • Nutrition and Healthcare Latest Trend
  • Tech
    • 3DPrinting
    • Artificial Intelligence
    • Automation
    • Blockchain
    • Big Data
    • Med Tech
    • Digital Health
    • Medical devices, equipment, and hospital supplies manufacturers
  • Clinical
    • Cardiology
    • Diabetes
    • Emergency Medicine
    • Obesitrics and Guneocology
    • Obesity
    • Oncology
    • Orthopedics
    • Otolaryngology
    • Padiatrics
    • Radiology
    • Surgery
  • Laboratories
    • Clinical Chemistry
    • Diagnostics
    • Gen Therapy
    • Immunology
    • IVF
    • Labratory Accrediation
    • Labratory Management
    • MicroBiology
  • Sectors
    • Optometry
    • Dental
    • Pharma
  • Magazine
  • Media Kit
No Result
View All Result
Arab Health World
No Result
View All Result
  • About Us
  • Cookie Policy
  • Privacy Policy
  • Terms of Use 
  • Contact
Home Sectors

Analysing aphasia to improve tech-assisted patient outcomes

Demand for assistive technology in aphasia treatment demonstrates rise in market value for healthcare mobile app developers. Farhana Chowdhury | Apr 13, 2022

admin by admin
February 21, 2023
in Sectors
0
0
Analysing aphasia to improve tech-assisted patient outcomes
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Hollywood actor Bruce Willis’ recent medical diagnosis generated a global buzz, bringing to light a little-known but important condition that affects speech. Aphasia is a communication disorder triggered by several factors including head injury, stroke, or a degenerative disease leading to permanent damage.

To put numbers into perspective, the National Aphasia Association states that at least two million people in the US are living with aphasia, out of which 225,000 were caused by strokes.

Related: Breaking Borders: Providing World-Class Treatment for Peripheral Nerve Disorders in U.S. & Abroad

“Each type of aphasia affects a specific area in the brain, so when this is taken over by any disease or pathology, the patient will present either motor, sensory, conductive, or nominal type. Stroke, brain tumour, multiple sclerosis, or any inflammatory disease can affect any area in the brain resulting in special aphasia according to the area involved,” said Dr Khalid Al-Saffar, a specialist in the Department of Neurology at Dubai-based Medcare Hospital Al Safa.

Rising demand for app-based solutions 

To date, language and speech therapy remains an effective treatment for aphasia patients, and statistics by Fortune Business Insights revealed a strong demand for dedicated software and mobile apps. The US Speech Therapy Market forecasts a CAGR of 5.8 per cent between 2021 and 2028, valued at US$6.08 billion in 2028, paving a strong route for manufacturers and software developers in healthcare. While there are no specific figures available in the Middle East region, experts are confident of the rising trends.

Related: Clinical Communication & Collaboration Platforms: Foundational Technology for Smart Hospitals

Assistive technology featuring the use of computers, smartphones, software, and related mobile apps could help pathologists and clinicians administer the right treatment and help people with aphasia communicate better.

The applications themselves take on different interfaces for an engaging and interactive patient experience. These can be in the form of games to practice speech and language-related tasks and exercises; and voice control that offers unlimited practice sessions without a speech therapist for articulation and pronunciation. Video therapy modules give patients a visual representation of tongue and throat movements, while flashcards assist with memory recall, learning new words and overcoming speech-language difficulties. Flashcards are particularly helpful for youth affected by aphasia as they can be modified to their needs.

The rise of technology in healthcare sparked research into virtual reality combined with speech therapy. Combined with apps, these augmentative tools offer alternative forms of communication and give patients a different approach to identifying words and holding conversations.

Inclusion is essential for patients 

Dr Al-Saffar explained that the region has a long way to go in addressing aphasia and executing the right treatments to retain the quality of life in patients. “The treating physician needs to address the symptoms and begin medical treatments guided by a speech therapist,” he added.

Once a patient is diagnosed with aphasia, the impact extends to family members and can cause a certain degree of mental stress, and strain on relationships. Dr Al-Saffar emphasised that practitioners need to ensure family members, and caregivers if any, are included in the rehabilitation process for better patient outcomes. This involves offering up-to-date information, raising awareness, and educating them on the current situation and future expectations.

What is aphasia?

Aphasia is the inability to speak caused by sustained trauma to the head or the result of a degenerative disease. Several celebrities are known to suffer from the condition, such as Hollywood actors Bruce Willis, Sharon Stone, and Game of Thrones star Emilia Clarke. The condition is divided into four categories — motor, sensory, conductive, and nominal:

Motor aphasia: The patient is unable express themselves and cannot pronounce words properly but can understand others’ language or command.
Sensory aphasia: The patient cannot understand others’ language or commands but can pronounce words properly.
Nominal dysphasia or aphasia: Patients can understand others, speak and pronounce words properly, but are unable to recall the names of objects.
Conductive dysphasia: Patients can understand, speak and pronounce words, but tend to mispronounce words.

Identifying symptoms of aphasia 

A clinical examination with the following steps can reveal the distinct types of aphasia in patients:

–        Ask the patient to talk about himself — what is his name, age, and address to detect his speech response.
–        Give commands. Patients should respond to instructions such as closing their eyes, raising their arms, etc. to detect their level of understanding.
–        Ask them to read a newspaper loudly to detect minimal defects in motor speech.
–        Ask them to respond to written commands to detect sensory aphasia.
–        Ask a patient to name a brand of item, like eyeglasses, shirt, or pen to detect the nominal aphasia.

Tags: ANALYTICSaphasia

Get real time update about this post categories directly on your device, subscribe now.

Unsubscribe
admin

admin

Related Posts

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb
Artificial Intellegance

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

by admin
April 30, 2025
0

No refractures were reported during long-term follow-up at five years At 24-months post-implantation, 89% of patients achieved bone union Novadip...

Read moreDetails

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

Sidra Medicine Publishes Impactful Study on Treatable Inherited Metabolic Disorders in Qatar

Sidra Medicine Launches Campaign Highlighting Commitment to Women’s and Children’s Health and Vision 2030

Treatment in Oman pavilion, under the Directorate General of Private Health Institutions, showcases Omani hospitals and medical institutions that rival international standards. Book your free visit now and experience excellence in healthcare!

Megatrends shaping healthcare in 2024

MEDICA 2024 + COMPAMED 2024: Know-how and innovations for the healthcare business – international and diverse with more than 6,000 exhibitors

Global Health Exhibition 2024

Stay Connected

  • 23.9k Followers
  • Trending
  • Comments
  • Latest
Neonatal resuscitation: A guide to the latest equipment

Neonatal resuscitation: A guide to the latest equipment

July 16, 2024
Dr. Raymond Liu, Vice-President, Mass General Brigham Global Advisory and Associate Radiologist for the Division of Interventional Radiology at Massachusetts General Hospital

Dr. Raymond Liu, Vice-President, Mass General Brigham Global Advisory and Associate Radiologist for the Division of Interventional Radiology at Massachusetts General Hospital

September 15, 2024
“Revolutionizing Medical Imaging: Saudi German Hospital Dubai’s State-of-the-Art 3 Tesla MRI Machine”

“Revolutionizing Medical Imaging: Saudi German Hospital Dubai’s State-of-the-Art 3 Tesla MRI Machine”

October 26, 2023
GCE Medical BRINGS FULL GLOBAL SUITE OF GAS Control equipment

GCE Medical BRINGS FULL GLOBAL SUITE OF GAS Control equipment

February 6, 2024

Medtech M&A outlook for 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound

0
FTC orders GoodRx to stop sharing users’ health data with advertisers, issues $1.5M fine

FTC orders GoodRx to stop sharing users’ health data with advertisers, issues $1.5M fine

0
World Cancer Day: Half of Cancer Deaths Can Be Prevented

World Cancer Day: Half of Cancer Deaths Can Be Prevented

0
Diabetes outlook: What Dexcom, Medtronic and other leaders are watching in 2023

Diabetes outlook: What Dexcom, Medtronic and other leaders are watching in 2023

0
Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

April 30, 2025
Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

April 7, 2025
Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

April 2, 2025
Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

February 27, 2025

Recent News

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

April 30, 2025
Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

April 7, 2025
Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

April 2, 2025
Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

February 27, 2025

Arab Health World

This magazine is newsworthy, analytical, and informative, providing readers with unique and professional content as well as opinions and editorials that will focus on medical and healthcare development. This specialty magazine is also the choice of healthcare professionals and informed readers who need an informed monthly source of news and information in the regional healthcare industry. We aim for excellence in our scientific, health and commercial reports.

Recent News

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

April 30, 2025
Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

April 7, 2025

Follow Us

  • About Us
  • Cookie Policy
  • Privacy Policy
  • Terms of Use 
  • Contact

© 2023 - ArabHealthWorld all rights reserved

Welcome Back!

Sign In with Facebook
Sign In with Google
Sign In with Linked In
OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Home
    • About Us
    • Cookie Policy
    • Privacy Policy
    • Terms of Use 
  • Business Insights
    • Accreditation
    • Healthcare Regulation
    • Infrastructure
    • Insurance
    • Leadership
    • Medical Tourism
    • Mental health
    • Medical Investment and Finance
    • Healthcare Regulation
    • Nutrition and Healthcare Latest Trend
  • Tech
    • 3DPrinting
    • Artificial Intelligence
    • Automation
    • Blockchain
    • Big Data
    • Med Tech
    • Digital Health
    • Medical devices, equipment, and hospital supplies manufacturers
  • Clinical
    • Cardiology
    • Diabetes
    • Emergency Medicine
    • Obesitrics and Guneocology
    • Obesity
    • Oncology
    • Orthopedics
    • Otolaryngology
    • Padiatrics
    • Radiology
    • Surgery
  • Laboratories
    • Clinical Chemistry
    • Diagnostics
    • Gen Therapy
    • Immunology
    • IVF
    • Labratory Accrediation
    • Labratory Management
    • MicroBiology
  • Sectors
    • Optometry
    • Dental
    • Pharma
  • Magazine
  • Media Kit

© 2023 - ArabHealthWorld all rights reserved